Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-22 Sale |
2022-08-24 07:50 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
55,500 | $10.07 | $558,696 | 9,376 (Direct) |
View |
| 2022-07-28 Sale |
2022-07-29 07:02 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
58,163 | $9.0365 | $525,590 | 2,974 (Direct) |
View |
| 2022-05-17 Sale |
2022-05-19 07:31 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
130,000 | $8.2159 | $1,068,067 | 1,387 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:13 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
32,311 | $7.45 | $240,718 | 263,012 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:07 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
33,579 | $7.4517 | $250,219 | 357,036 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-07 Option Award |
2023-02-09 07:02 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
42,309 | $0 | 42,309 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:01 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
50,242 | $0 | 50,242 (Direct) |
View |
| 2022-11-04 Exercise |
2022-11-07 07:02 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
12,205 | $0 | 12,222 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 08:55 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
116,389 | $0 | 1,542,471 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-11 07:05 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
1,581 | $0 | 19,741 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:29 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:27 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:25 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:24 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Peres Nechemia Jacob Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:22 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:21 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:19 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:18 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Halfon Jean Michel Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:16 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:13 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
15,810 | $0 | 15,810 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-08 07:10 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
28,162 | $0 | 28,162 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-03 07:14 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
210,970 | $0 | 210,970 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:44 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
14,479 | $0 | 27,147 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:42 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
14,479 | $0 | 51,359 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:41 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Peres Nechemia Jacob Director |
14,479 | $0 | 58,765 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:40 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
14,479 | $0 | 58,765 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:39 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
14,479 | $0 | 1,558,765 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
14,479 | $0 | 69,107 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Halfon Jean Michel Director |
14,479 | $0 | 63,707 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:34 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
14,479 | $0 | 2,057,413 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
14,479 | $0 | 66,697 (Direct) |
View |
| 2022-06-14 Exercise |
2022-06-16 07:32 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
25,791 | $0 | 343,354 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
5,967 | $0 | 80,365 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
42,707 | $0 | 80,365 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
72,068 | $0 | 263,012 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
127,345 | $0 | 263,012 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
9,069 | $0 | 119,451 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
80,428 | $0 | 119,451 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
293,586 | $0 | 2,101,807 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
402,144 | $0 | 2,101,807 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
83,042 | $0 | 398,907 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
134,048 | $0 | 398,907 (Direct) |
View |
| 2022-03-05 Exercise |
2022-03-08 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
21,387 | $0 | 263,088 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
134,048 | $0 | 263,088 (Direct) |
View |
| 2022-03-05 Exercise |
2022-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
5,710 | $0 | 112,926 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
80,428 | $0 | 112,926 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
94,157 | $0 | 357,036 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
140,750 | $0 | 357,036 (Direct) |
View |